Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Becton Dickinson and Co BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring solutions and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.


NYSE:BDX - Post by User

Post by zayaroy18on Jun 16, 2022 4:52am
260 Views
Post# 34760371

Live Cell Imaging Market Report Size, Share, Trends Report

Live Cell Imaging Market Report Size, Share, Trends Report

According to the latest report by IMARC Group, titled “Live Cell Imaging Market Size: Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026”, the global live cell imaging market exhibited moderate growth during 2015-2020 and expects the market to grow at a CAGR of around 8% during 2021-2026

Live cell imaging refers to a microscopy technique that allows in vivo imaging of cell structures. It aids scientists in obtaining valuable information on biological processes, including movement with time resolution and molecular localization. Live cell imaging also assists in studying dynamic complex assembly and interaction between molecules, cellular responses to environmental cues, viral particle behavior, etc. In recent times, numerous technological advancements, such as algorithms and data analysis, are enabling the monitoring of molecules within animals.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Live Cell Imaging Market Trends:

The elevating incidences of chronic and lifestyle diseases and the expanding healthcare provision are driving the live cell imaging market. Furthermore, live cell imaging can be utilized in monitoring exocytosis, endocytosis, protein trafficking, cellular integrity, enzyme activity, signal transduction, etc. As a result, it is gaining preference over fixed cell imaging that usually requires a long exposure time and high illumination intensity. Additionally, various improvements in camera technology, sensitivity, pixel density, etc., are leading to advances in quantitative phase contrast, which is enabling image capture at different focal planes from one exposure. Besides this, several researchers are utilizing live cell imaging to get biologically relevant data as these images can be automatically processed to extract information from dynamic cells. Apart from this, the increasing government funding and investments in medical research and development (R&D) projects are expected to catalyze the market growth over the forecasted period.

Request Free Sample Report: https://www.imarcgroup.com/live-cell-imaging-market/requestsample

Global Live Cell Imaging Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Becton Dickinson and Company, Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Merck KGaA, Nikon Instruments Inc, Olympus Corporation, PerkinElmer Inc and Thermo Fisher Scientific Inc.

The report has segmented the market on the basis on region, product, application and technology.

Breakup by Product:

  • Equipment
  • Consumable
  • Software

Breakup by Application:

  • Cell Biology
  • Developmental Biology
  • Stem Cell and Drug Discovery
  • Others

Breakup by Technology:

  • Time-Lapse Microscopy
  • Fluorescence Recovery after Photobleaching (FRAP)
  • Fluorescence Resonance Energy Transfer (FRET)
  • High Content Screening (HCS)
  • Others

Breakup by Region:

  • North America:( United States, Canada)
  • Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico,Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/live-cell-imaging-market

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2015-2020)
  • Market Outlook (2021- 2026)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

Company Name: IMARC Group
Email: sales@imarcgroup.com
Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

<< Previous
Bullboard Posts
Next >>